Close Menu

NEW YORK (GenomeWeb News) — Case Western Reserve University has received a grant worth up to $3 million from the National Institute of Drug Abuse to conduct proteomic studies of Hepatitis C and HIV infections, Case's School of Medicine said today.

The three-year NIDA grant will fund development of proteomic and epigenetic markers for chronic immune activation during HIV disease and studies of the effects of current and prior drug use and HCV infection on disease progression and therapy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Apr
17
Sponsored by
Isoplexis

This webinar will provide an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers.